Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jan;6(1):77-84.
doi: 10.1007/s11910-996-0012-0.

Current therapies for neuromuscular manifestations of paraneoplastic syndromes

Affiliations

Current therapies for neuromuscular manifestations of paraneoplastic syndromes

Myrna R Rosenfeld et al. Curr Neurol Neurosci Rep. 2006 Jan.

Abstract

The neuromuscular manifestations of paraneoplastic disorders result in diverse syndromes that may also occur in patients without cancer. In general, treatment of these disorders is the same whether or not there is an underlying malignancy. However, when the disorder is believed to be paraneoplastic, the main concern should be prompt detection and treatment of the tumor, as this has been shown to offer the best chance for neurologic stabilization or improvement. The paraneoplastic neuromuscular disorders can be divided into two main categories: those that are directly mediated by antibodies and those that are believed to result from other immune-mediated mechanisms, including cytotoxic T-cell responses with or without association with specific antibodies. For disorders in which the antibodies are pathogenic, therapy is aimed at removing the antibodies. For the other disorders, adjuvant therapies are for the most part empiric and include a variety of immunosuppressant and immunomodulatory agents.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain. 2001 Jun;124(Pt 6):1138-48 - PubMed
    1. J Neurol Sci. 1989 Feb;89(2-3):253-67 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1999 Jul;67(1):7-14 - PubMed
    1. Brain. 2004 Oct;127(Pt 10):2331-8 - PubMed
    1. Semin Oncol. 2003 Apr;30(2):178-81 - PubMed

MeSH terms

LinkOut - more resources